Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 202

1.

Comparison of NITAG policies and working processes in selected developed countries.

Ricciardi GW, Toumi M, Weil-Olivier C, Ruitenberg EJ, Dankó D, Duru G, Picazo J, Zöllner Y, Poland G, Drummond M.

Vaccine. 2015 Jan 1;33(1):3-11. doi: 10.1016/j.vaccine.2014.09.023. Epub 2014 Sep 23.

2.

Preparing for the next public debate: universal vaccination against hepatitis B.

Houweling H, Spaendonck MC, Paulussen T, Verweij M, Ruitenberg EJ.

Vaccine. 2011 Nov 8;29(48):8960-4. doi: 10.1016/j.vaccine.2011.09.042. Epub 2011 Sep 21.

PMID:
21945254
3.

Public vaccination programmes against hepatitis B in The Netherlands: assessing whether a targeted or a universal approach is appropriate.

Houweling H, Wittevrongel CF, Verweij M, Ruitenberg EJ; National Immunisation Programme Review Committee of the Health Council of the Netherlands.

Vaccine. 2010 Nov 16;28(49):7723-30. doi: 10.1016/j.vaccine.2010.09.068. Epub 2010 Oct 14.

PMID:
20933042
4.

The global introduction of inactivated polio vaccine can circumvent the oral polio vaccine paradox.

Heinsbroek E, Ruitenberg EJ.

Vaccine. 2010 May 14;28(22):3778-83. doi: 10.1016/j.vaccine.2010.02.095. Epub 2010 Apr 1. Review.

PMID:
20362626
5.

Criteria for inclusion of vaccinations in public programmes.

Houweling H, Verweij M, Ruitenberg EJ; National Immunisation Programme Review Committee of the Health Council of the Netherlands.

Vaccine. 2010 Apr 9;28(17):2924-31. doi: 10.1016/j.vaccine.2010.02.021. Epub 2010 Feb 26. Review.

PMID:
20189486
6.

Motivation of university and non-university stakeholders to change medical education in Vietnam.

Luu NH, Nguyen LV, van der Wilt GJ, Broerse J, Ruitenberg EJ, Wright EP.

BMC Med Educ. 2009 Jul 24;9:49. doi: 10.1186/1472-6920-9-49.

7.

Evaluation of diphtheria convalescent patients to serve as donors for the production of anti-diphtheria immunoglobulin preparations.

Bissumbhar B, Rakhmanova AG, Berbers GA, Iakolev A, Nosikova E, Melnick O, Ovtcharenko E, Rümke HC, Ruitenberg EJ.

Vaccine. 2004 May 7;22(15-16):1886-91.

PMID:
15121299
8.

Pharmaco-economics of blood transfusion safety: review of the available evidence.

van Hulst M, de Wolf JT, Staginnus U, Ruitenberg EJ, Postma MJ.

Vox Sang. 2002 Aug;83(2):146-55. Review.

PMID:
12201844
9.

[Universal vaccination against group-C meningococci and pneumococci; summary of the advice from the Health Counsil of the Netherlands].

Ruitenberg EJ, Houweling H.

Ned Tijdschr Geneeskd. 2002 May 18;146(20):938-40. Dutch.

PMID:
12051061
10.

Infection of a canine macrophage cell line with leishmania infantum: determination of nitric oxide production and anti-leishmanial activity.

Pinelli E, Gebhard D, Mommaas AM, van Hoeij M, Langermans JA, Ruitenberg EJ, Rutten VP.

Vet Parasitol. 2000 Oct 1;92(3):181-9.

PMID:
10962155
11.

Detection of canine cytokine gene expression by reverse transcription-polymerase chain reaction.

Pinelli E, van der Kaaij SY, Slappendel R, Fragio C, Ruitenberg EJ, Bernadina W, Rutten VP.

Vet Immunol Immunopathol. 1999 Aug 2;69(2-4):121-6.

PMID:
10507299
12.

Measurement of dog cytokines by reverse transcription-quantitative competitive polymerase chain reaction.

Pinelli E, van der Kaaij SY, Broeren CP, Ruitenberg EJ, Rutten VP.

Immunogenetics. 1999 Jul;49(7-8):696-9. No abstract available.

PMID:
10369929
13.

Molecular cloning and sequencing of the cDNA for dog interleukin-4.

van der Kaaij SY, Pinelli E, Broeren CP, Schetters TP, Haghparast A, Ruitenberg EJ, Rutten VP.

Immunogenetics. 1999 Feb;49(2):142-3. No abstract available.

PMID:
9887351
15.

Optimal regimes for local IL-2 tumour therapy.

Den Otter W, De Groot JW, Bernsen MR, Heintz AP, Maas R, Hordijk GJ, Hill FW, Klein WR, Ruitenberg EJ, Rutten VP.

Int J Cancer. 1996 May 3;66(3):400-3.

16.

Ocular squamous cell carcinoma in Simmental cattle in Zimbabwe.

Den Otter W, Hill FW, Klein WR, Everse LA, Ruitenberg EJ, Van der Ven LT, Koten JW, Steerenberg PA, Faber JA, Rutten VP.

Am J Vet Res. 1995 Nov;56(11):1440-4.

PMID:
8585653
17.

Therapy of bovine ocular squamous-cell carcinoma with local doses of interleukin-2: 67% complete regressions after 20 months of follow-up.

Den Otter W, Hill FW, Klein WR, Koten JW, Steerenberg PA, De Mulder PH, Rhode C, Stewart R, Faber JA, Ruitenberg EJ, et al.

Cancer Immunol Immunother. 1995 Jul;41(1):10-4.

PMID:
7641215
18.

[An overview of veterinary medicine from 1960 to today with a look toward the future].

Ruitenberg EJ.

Tijdschr Diergeneeskd. 1995 Jul 15-Aug 1;120(14):436-9. Dutch. No abstract available.

PMID:
7624845
19.

Leishmania infantum-specific T cell lines derived from asymptomatic dogs that lyse infected macrophages in a major histocompatibility complex-restricted manner.

Pinelli E, Gonzalo RM, Boog CJ, Rutten VP, Gebhard D, del Real G, Ruitenberg EJ.

Eur J Immunol. 1995 Jun;25(6):1594-600.

PMID:
7614987
20.

Local bacillus Calmette-Guérin therapy for bovine vulval papilloma and carcinoma.

Hill FW, Rutten VP, Hoyer MH, Klein WR, Koten JW, Steerenberg PA, Ruitenberg EJ, Den Otter W.

Cancer Immunol Immunother. 1994 Jul;39(1):49-52.

PMID:
8044826

Supplemental Content

Loading ...
Support Center